176 related articles for article (PubMed ID: 24023715)
1. DYRK2 negatively regulates cardiomyocyte growth by mediating repressor function of GSK-3β on eIF2Bε.
Weiss CS; Ochs MM; Hagenmueller M; Streit MR; Malekar P; Riffel JH; Buss SJ; Weiss KH; Sadoshima J; Katus HA; Hardt SE
PLoS One; 2013; 8(9):e70848. PubMed ID: 24023715
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
Deng H; Dokshin GA; Lei J; Goldsmith AM; Bitar KN; Fingar DC; Hershenson MB; Bentley JK
J Biol Chem; 2008 Apr; 283(15):10198-207. PubMed ID: 18252708
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells.
Mariappan MM; Shetty M; Sataranatarajan K; Choudhury GG; Kasinath BS
J Biol Chem; 2008 Nov; 283(45):30566-75. PubMed ID: 18701453
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of eukaryotic initiation factor eIF2Bepsilon in skeletal muscle during sepsis.
Vary TC; Deiter G; Kimball SR
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1032-9. PubMed ID: 12376332
[TBL] [Abstract][Full Text] [Related]
7. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
Pap M; Cooper GM
Mol Cell Biol; 2002 Jan; 22(2):578-86. PubMed ID: 11756553
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
9. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
Cho J; Zhai P; Maejima Y; Sadoshima J
Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
11. DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping.
Kurabayashi N; Hirota T; Sakai M; Sanada K; Fukada Y
Mol Cell Biol; 2010 Apr; 30(7):1757-68. PubMed ID: 20123978
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
13. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
Woods YL; Cohen P; Becker W; Jakes R; Goedert M; Wang X; Proud CG
Biochem J; 2001 May; 355(Pt 3):609-15. PubMed ID: 11311121
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
Yin H; Chao L; Chao J
J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141
[TBL] [Abstract][Full Text] [Related]
15. GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.
Zhou J; Lal H; Chen X; Shang X; Song J; Li Y; Kerkela R; Doble BW; MacAulay K; DeCaul M; Koch WJ; Farber J; Woodgett J; Gao E; Force T
J Clin Invest; 2010 Jul; 120(7):2280-91. PubMed ID: 20516643
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
Song WJ; Song EA; Jung MS; Choi SH; Baik HH; Jin BK; Kim JH; Chung SH
J Biol Chem; 2015 Jan; 290(4):2321-33. PubMed ID: 25477508
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
18. The AMPK gamma1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes.
Folmes KD; Witters LA; Allard MF; Young ME; Dyck JR
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3456-64. PubMed ID: 17906100
[TBL] [Abstract][Full Text] [Related]
19. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes.
Kawasaki Y; Kugimiya F; Chikuda H; Kamekura S; Ikeda T; Kawamura N; Saito T; Shinoda Y; Higashikawa A; Yano F; Ogasawara T; Ogata N; Hoshi K; Hofmann F; Woodgett JR; Nakamura K; Chung UI; Kawaguchi H
J Clin Invest; 2008 Jul; 118(7):2506-15. PubMed ID: 18551195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
